Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018
- PMID: 32701937
- PMCID: PMC7377821
- DOI: 10.15585/mmwr.mm6929a1
Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness - United States, 2018
Abstract
Risk for severe coronavirus disease 2019 (COVID-19)-associated illness (illness requiring hospitalization, intensive care unit [ICU] admission, mechanical ventilation, or resulting in death) increases with increasing age as well as presence of underlying medical conditions that have shown strong and consistent evidence, including chronic obstructive pulmonary disease, cardiovascular disease, diabetes, chronic kidney disease, and obesity (1-4). Identifying and describing the prevalence of these conditions at the local level can help guide decision-making and efforts to prevent or control severe COVID-19-associated illness. Below state-level estimates, there is a lack of standardized publicly available data on underlying medical conditions that increase the risk for severe COVID-19-associated illness. A small area estimation approach was used to estimate county-level prevalence of selected conditions associated with severe COVID-19 disease among U.S. adults aged ≥18 years (5,6) using self-reported data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) and U.S. Census population data. The median prevalence of any underlying medical condition in residents among 3,142 counties in all 50 states and the District of Columbia (DC) was 47.2% (range = 22.0%-66.2%); counties with the highest prevalence were concentrated in the Southeast and Appalachian region. Whereas the estimated number of persons with any underlying medical condition was higher in population-dense metropolitan areas, overall prevalence was higher in rural nonmetropolitan areas. These data can provide important local-level information about the estimated number and proportion of persons with certain underlying medical conditions to help guide decisions regarding additional resource investment, and mitigation and prevention measures to slow the spread of COVID-19.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
Similar articles
-
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32240123 Free PMC article.
-
Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.Eur J Epidemiol. 2020 May;35(5):401-409. doi: 10.1007/s10654-020-00646-z. Epub 2020 May 18. Eur J Epidemiol. 2020. PMID: 32424571 Free PMC article.
-
Health-Related Behaviors by Urban-Rural County Classification - United States, 2013.MMWR Surveill Summ. 2017 Feb 3;66(5):1-8. doi: 10.15585/mmwr.ss6605a1. MMWR Surveill Summ. 2017. PMID: 28151923 Free PMC article.
-
Epidemiology of the 2020 Pandemic of COVID-19 in the State of Texas: The First Month of Community Spread.J Community Health. 2020 Aug;45(4):696-701. doi: 10.1007/s10900-020-00854-4. J Community Health. 2020. PMID: 32500438 Free PMC article. Review.
-
Updated overview on the interplay between obesity and COVID-19.Diagnosis (Berl). 2020 Nov 19;8(1):5-16. doi: 10.1515/dx-2020-0111. Print 2021 Feb 23. Diagnosis (Berl). 2020. PMID: 33544485 Review.
Cited by
-
Association of race/ethnicity and severe housing problems with COVID-19 deaths in the United States: Analysis of the first three waves.PLoS One. 2024 May 29;19(5):e0303667. doi: 10.1371/journal.pone.0303667. eCollection 2024. PLoS One. 2024. PMID: 38809908 Free PMC article.
-
Experience of Public Health Departments in Implementation of COVID-19 Case Investigation and Contact Tracing Programs.Public Health Rep. 2024 Nov-Dec;139(6):734-743. doi: 10.1177/00333549241239556. Epub 2024 May 23. Public Health Rep. 2024. PMID: 38779998
-
Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization, 2020 to 2023.Open Forum Infect Dis. 2024 Apr 5;11(5):ofae197. doi: 10.1093/ofid/ofae197. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38698896 Free PMC article.
-
Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.PLoS One. 2024 Mar 27;19(3):e0300872. doi: 10.1371/journal.pone.0300872. eCollection 2024. PLoS One. 2024. PMID: 38536876 Free PMC article.
-
Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States.J Manag Care Spec Pharm. 2023 Dec;29(12):1290-1302. doi: 10.18553/jmcp.2023.29.12.1290. J Manag Care Spec Pharm. 2023. PMID: 38058141 Free PMC article.
References
-
- Chow N, Fleming-Dutra K, Gierke R, et al.; CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–6. 10.15585/mmwr.mm6913e2 - DOI - PMC - PubMed
-
- CDC. Coronavirus disease 2019 (COVID-19). Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidenc...
-
- Zhang X, Holt JB, Lu H, et al. Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system. Am J Epidemiol 2014;179:1025–33. 10.1093/aje/kwu018 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical

